Furthermore, we show that CD69+FoxP3+ and TIGIT+FoxP3+ Treg subsets are induced by VD3-primed DCs, which are especially beneficial for the targeted suppression of pathogenic Th17 cell responses that contribute to disease progression in psoriasis and rheumatoid arthritis, among others (1, 2). This evidence concerns the gene FOXP3 and psoriasis.